MIRA
INFORM REPORT
|
Report Date : |
13.01.2012 |
IDENTIFICATION DETAILS
|
Name : |
BEIJING LIANBEN PHARMA-CHEMICALS TECH CO., LTD |
|
|
|
|
Registered Office : |
Suite 4A10, Changyin Building, No. 88 Yongding Road, Haidian
District, Beijing 100039 Pr |
|
|
|
|
Country : |
China |
|
|
|
|
Financials (as on) : |
31.12.2010 |
|
|
|
|
Date of Incorporation : |
19.01.2004 |
|
|
|
|
Com. Reg. No.: |
110108006422155 |
|
|
|
|
Legal Form : |
Limited Liabilities Company |
|
|
|
|
Line of Business : |
Selling Pharmaceutical Raw Materials, Pharmaceutical
Intermediates. |
|
|
|
|
No. of Employees : |
48 |
RATING & COMMENTS
|
MIRA’s Rating : |
B |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
Maximum Credit Limit : |
USD 100,000 |
|
Status : |
Moderate |
|
Payment Behaviour : |
No Complaints |
|
Litigation : |
Clear |
NOTES :
Any query related to this report can be made
on e-mail: infodept@mirainform.com while quoting report
number, name and date.
ECGC Country Risk Classification List – September 30, 2011
|
Country Name |
Previous Rating (30.06.2011) |
Current Rating (30.09.2011) |
|
China |
A2 |
A2 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
sc’s INFO.
BEIJING LIANBEN PHARMA-CHEMICALS TECH CO., LTD.
SUITE
88 4A10
TEL: 86 (0) 10-51606977
FAX: 86 (0) 10-51606977
EXECUTIVE SUMMARY
Date of Registration :
january 19, 2004
REGISTRATION NO. :
110108006422155
LEGAL FORM :
Limited liabilities company
CHIEF EXECUTIVE :
guo rongyao (LEGAL REPRESENTATIVE)
REGISTERED CAPITAL : cny 500,000
staff :
48
BUSINESS CATEGORY : trading
Revenue :
CNY 37,895,000 (AS OF DEC. 31, 2010)
EQUITIES :
CNY 11,049,000 (AS OF DEC. 31, 2010)
WEBSITE :
www.lianben.com
E-MAIL :
contact@lianben.com
PAYMENT :
AVERAGE
Recommended Credit Limit :
UP TO USD 100,000
MARKET CONDITION :
average
FINANCIAL CONDITION :
stable
OPERATIONAL TREND : STEADY
GENERAL REPUTATION :
AVERAGE
EXCHANGE RATE :
CNY 6.31 = USD 1
Adopted
abbreviations (as follows)
SC - Subject Company (the company inquired by you)
N/A – Not available
CNY – China Yuan Ren Min Bi
OPERATIONAL TREND & GENERAL
REPUTATION
This section aims at indicating the relative positions of SC
in respect of its operational trend & general reputation
Operational Trend:- General
Reputation:-
Upward Excellent
Steady Good
Fairly Steady Fairly
Good
Ordinary Average
Fair Fair
Stagnant Detrimental
Downward Not
known
Not known Not
yet be determined
Not yet be determined
LEGAL STATUS & HISTORY
SC was established as a limited liabilities company of PRC
with State Administration of Industry & Commerce (SAIC) under registration
No.: 110108006422155 on January 19, 2004.
SC’s Organization Code Certificate No.: 75821583-0
SC’s registered capital: cny 500,000
SC’s paid-in capital: cny 500,000
Registration
Change Record:
|
Date |
Change of Contents |
Before the change |
After the change |
|
2011 |
Legal Representative |
Li Gongben |
Guo Rongyao |
Current
Co search indicates SC’s shareholders & chief executives are as follows:-
|
Name of Shareholder (s) |
% of Shareholding |
|
Ding Juping |
30 |
|
Li Gongben |
40 |
|
Guo Rongyao |
30 |
SC’s
Chief Executives:-
|
Position |
Name |
|
Legal Representative and Chairman |
Guo Rongyao |
|
General Manager |
Ding Juping |
|
Supervisor |
Lv Guanfeng |
RECENT DEVELOPMENT
No recent development was found during our checks at
present.
SHAREHOLDER CHART &
BACKGROUND
Name %
of Shareholding
Ding Juping 30
Li Gongben 40
Guo Rongyao 30
MANAGEMENT
Guo Rongyao, Legal Representative and Chairman
------------------------------------------------------------------------------
Gender: M
Age: 43
ID# 150122196908133019
Qualification: University
Working experience (s):
From 2011 to present, working in SC as legal representative
and chairman
Ding Juping, General Manager
----------------------------------------------------
Gender: M
Age: 43
ID# 110104196908120015
Qualification: University
Working experience (s):
At present, working in SC as general manager
Also working in Beijing Merrychem Pharmaceutical Co., Ltd.
as legal representative and chairman
Lv Guanfeng, Supervisor
--------------------------------------------
Gender: M
Age: 36
ID# 432623197607170016
Qualification: University
BUSINESS OPERATION
SC’s registered business scope
includes technical services, technology promotion; importing and
exporting goods and technology, import and export agent; investment management;
investment consultation, economic and trade consultation; organizational
culture and art exchange activities; conference services, exhibition
contractor; computer animation design; design and production advertising;
selling daily necessities, hardware, chemical products, handicrafts, construction
materials, machinery, household appliances, rubber products, computers,
software and auxiliary equipment, communications equipment, electronic
products, stationery, sports goods.
SC is mainly engaged in selling pharmaceutical raw
materials, pharmaceutical intermediates.
SC’s products mainly include:
Methyl 6-methyl-2-(4-methylphenyl)
imidazo [1,2-a]pyridine-3-acetate
6-Methyl-2-(4-methylphenyl) imidazol
[1,2-a]-pyridine-3-acetic acid
Tolterodine hydrobromide
3-(2-Methoxy-5-methylphenyl)-3-phenylpropanol
hydrochloride
3-(2-Methoxy-5-methylphenyl)-3-phenylpropanoic
acid
N-Methyl-4-diazanylsulfabenzamide
2-(3-Carbethoxy-4-hydroxypyrrolidin-2-on-1-yl)
ethyl acetate
Methyl
6,11-dihydro-11-oxo-dibenz[b,e]oxepin-2-acetate
4-Methoxy-alpha-methyl-N-(phenylmethyl)benzeneethanamine
Etc.
SC sources its materials 100% from domestic market. SC sells
15% of its products in domestic market, and 85% to overseas market, mainly
America, Japan, Korea, Southeast Asia, India, Pakistan, Middle East, etc..
The buying terms of SC include T/T and Credit of 30-60 days.
The payment terms of SC include T/T, L/C and Credit of 30-60 days.
Staff
& Office:
SC is known to have approx. 48 staff at present.
SC rents an area as its operating office, but the detailed information
is unknown.
RELATED COMPANY
Related
Company:
Beijing Merrychem Pharmaceutical Co., Ltd.
Date of Registration: July 22, 2002
Registration No.: 110108003971488
Legal Form: Limited Liabilities Company
Chief Executive: Ding Juping
Registered Capital:
CNY 500,000
Branch:
Beijing Lianben Pharma-Chemicals Tech Co., Ltd. Fengtai
Branch
Date of Registration: October 27, 2008
Registration No.: 110106011404751
Legal Form: Branch Company
Chief Executive: Li Gongben
PAYMENT
Overall payment appraisal:
( ) Excellent ( )
Good (X) Average ( ) Fair ( ) Poor ( ) Not yet be determined
The appraisal serves as a reference to reveal SC's payments
habits and ability to pay. It is based
on the 3 weighed factors: Trade payment experience (through current enquiry
with SC's suppliers), our delinquent payment and our debt collection record
concerning SC.
Trade payment experience: SC did not provide any name of
trade/service suppliers and we have no other sources to conduct the enquiry at
present.
Delinquent payment record: None in our database.
Debt collection record: No overdue amount owed by SC was
placed to us for collection within the last 6 years.
BANKING
Basic
Bank:
Industrial and Commercial Bank of China
Beijing Yongding Road Sub-branch
AC#:
0200004919200058280
FINANCIALS
Financial Summary
|
Unit:
CNY’000 |
As of Dec. 31, 2010 |
|
Long term investment |
0 |
|
Total assets |
25,724 |
|
|
------------- |
|
Long term
liabilities |
0 |
|
Total liabilities |
14,675 |
|
Equities |
11,049 |
|
|
------------- |
|
Revenue |
37,895 |
|
Profit before tax |
7,872 |
|
Less: profit tax |
1,968 |
|
Profits |
5,904 |
Note: The detailed financials
for Y2010 are not available in SAIC.
Important
Ratios
|
|
As of Dec. 31, 2010 |
|
*Liabilities to assets |
0.57 |
|
*Net profit margin (%) |
15.58 |
|
*Return on total assets (%) |
22.95 |
|
* Revenue/Total assets |
1.47 |
FINANCIAL COMMENTS
PROFITABILITY:
FAIRLY GOOD
The revenue of SC appears average in its line.
SC’s net profit margin is fairly good.
SC’s return on total assets is fairly good.
LIQUIDITY:
AVERAGE
SC’s revenue is in an average level, comparing with the size
of its total assets.
LEVERAGE:
AVERAGE
The debt ratio of SC is average.
The risk for SC to go bankrupt is average.
Overall financial condition of the SC: Stable.
CONCLUSIONS
SC is considered medium-sized in its line with stable
financial conditions. A credit line up to USD 100,000 would appear to be within
SC’s capacities.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.51.82 |
|
|
1 |
Rs.79.42 |
|
Euro |
1 |
Rs.65.90 |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit transaction.
It has above average (strong) capability for payment of interest and
principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General unfavourable
factors will not cause fatal effect. Satisfactory capability for payment of
interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with full
security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
---- |
NB |
New Business |
---- |
This score serves as a reference to assess SC’s credit risk and
to set the amount of credit to be extended. It is calculated from a composite
of weighted scores obtained from each of the major sections of this report. The
assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.